NextCure Inc.

NASDAQ: NXTC · Real-Time Price · USD
0.50
0.03 (5.69%)
At close: Jun 05, 2025, 3:59 PM
0.50
-0.02%
After-hours: Jun 05, 2025, 06:15 PM EDT

NextCure Statistics

Share Statistics

NextCure has 28.05M shares outstanding. The number of shares has increased by 0.12% in one year.

28.05M
0.12%
0%
57.32%
n/a
300
0.18%

Short Selling Information

The latest short interest is 317.03K, so 1.13% of the outstanding shares have been sold short.

317.03K
1.13%
1.15%
2.29

Valuation Ratios

The PE ratio is -0.39 and the forward PE ratio is -0.33. NextCure's PEG ratio is 0.03.

-0.39
-0.33
0
0.6
0.33
-0.52
0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for NextCure.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 7.5, with a Debt / Equity ratio of 0.09.

7.5
7.5
0.09
-0.11
-0.14
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1,294,279.07
43
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -64.49% in the last 52 weeks. The beta is 1.08, so NextCure's price volatility has been higher than the market average.

1.08
-64.49%
0.43
0.94
51.38
168,328

Income Statement

n/a
n/a
-59.75M
-55.65M
-52.79M
-57.21M
-1.99
Full Income Statement

Balance Sheet

The company has 27.73M in cash and 5.95M in debt, giving a net cash position of 21.78M.

27.73M
5.95M
21.78M
-380.14M
67.14M
53.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -40.8M and capital expenditures -474K, giving a free cash flow of -41.28M.

-40.8M
-474K
-41.28M
-1.48
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

NXTC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for NXTC is $3.5, which is 614.3% higher than the current price. The consensus rating is "Buy".

$3.5
614.3%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-9.05
1